Bankruptcy Bid: XNK Therapeutics

XNK Therapeutics AB was declared bankrupt on April 9, 2024. The Södertörns District Court appointed Anders Svensson Clark as bankruptcy trustee.

XNK Therapeutics is a clinical-stage biotechnology company developing unique and individualized natural killer cell-based cancer therapies.

If you wish to submit a bid on the company’s business and/or assets, please contact anders.svensson.clark@se.dlapiper.com and therese.isaksson@se.dlapiper.com.

Please note that all bids should be submitted by April 26, 2024 at the latest.